Pyloric stenosis associated Crohn's disease responding to adalimumab therapy

doi:10.4292/wjgpt.v3.i6.97

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3025)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

291

HTML

2479

Figures (1-1)

255

Sum=3025

Dec 6, 2012 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Pharmacol Ther. Dec 6, 2012; 3(6): 97-99
Published online Dec 6, 2012. doi: 10.4292/wjgpt.v3.i6.97

Open in New Tab Full Size Figure Download Figure

Figure 1 Magnetic resonance imaging. A: Gross gastric dilatation before anti-tumor necrosis factor therapy; B: Significantly reduced stomach size but with some focal small intestinal dilatation.

Citation: Gaggar S, Scott J, Thompson N. Pyloric stenosis associated Crohn's disease responding to adalimumab therapy. World J Gastrointest Pharmacol Ther 2012; 3(6): 97-99
URL: https://www.wjgnet.com/2150-5349/full/v3/i6/97.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v3.i6.97